| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018006633 |
| P356 | DOI | 10.1007/BF01973598 |
| P698 | PubMed publication ID | 7875148 |
| P2093 | author name string | J S Carvalho | |
| R Badaró | |||
| T C Jones | |||
| W D Johnson | |||
| S G Reed | |||
| J L Ho | |||
| D Russo | |||
| C Nascimento | |||
| F Badaró | |||
| P2860 | cites work | Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis | Q24563719 |
| Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis | Q24633365 | ||
| Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes | Q29619621 | ||
| Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical Studies | Q34234692 | ||
| Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated | Q34568193 | ||
| Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). | Q35320608 | ||
| Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). | Q35322415 | ||
| Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory | Q36229797 | ||
| Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma | Q36354239 | ||
| Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages | Q36357479 | ||
| Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production | Q37517951 | ||
| Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine | Q39239034 | ||
| Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas | Q40711316 | ||
| Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma | Q40765813 | ||
| New perspectives on a subclinical form of visceral leishmaniasis | Q40802948 | ||
| The effects of rhGM-CSF on macrophage function | Q40858798 | ||
| The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis | Q40875846 | ||
| A prospective study of visceral leishmaniasis in an endemic area of Brazil. | Q50575676 | ||
| Control of the leishmaniases. Report of a WHO Expert Committee | Q56779328 | ||
| Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis | Q67298201 | ||
| Interleukin-4 Inhibits Human Macrophage Activation by Tumor Necrosis Factor, Granulocyte-Monocyte Colony-Stimulating Factor, and Interleukin-3 for Antileishmanial Activity and Oxidative Burst Capacity | Q67485674 | ||
| Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin Disease | Q67719984 | ||
| Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation | Q68059242 | ||
| Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans | Q68455389 | ||
| Bacterial infections in patients with visceral leishmaniasis | Q68587488 | ||
| Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis | Q71756849 | ||
| Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis | Q72069425 | ||
| P921 | main subject | macrophage | Q184204 |
| visceral leishmaniasis | Q2046113 | ||
| antimony(5+) cation | Q27269467 | ||
| P304 | page(s) | S23-8 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis | |
| P478 | volume | 13 Suppl 2 |
| Q53925920 | Intermittent short duration therapy with fluconazole is effective for tinea capitis. |
| Q36374716 | RecombinantLeishmania majorSecreting Biologically Active Granulocyte-Macrophage Colony-Stimulating Factor Survives Poorly in Macrophages In Vitro and Delays Disease Development in Mice |
| Q33706507 | The potential for monocyte-mediated immunotherapy during infection and malignancy--Part II: in vivo activation by exogenous cytokines and clinical applications |
| Q74582128 | Therapeutic and prophylactic uses of protein A in the control of Leishmania donovani infection in experimental animals |
| Q92134330 | Visceral leishmaniasis: An overview of vaccine adjuvants and their applications |
Search more.